Ein Mann liest Wirtschaftsnachrichten (Symbolbild).
Montag, 07.04.2014 11:45 von GlobeNewswire | Aufrufe: 155

Solvay applies new IFRS reporting standards in 2014 and restates 2013 financials accordingly

Ein Mann liest Wirtschaftsnachrichten (Symbolbild). pixabay.com

Highlights:

  • IFRS 10, 11 and 12 adopted since January 1st 2014
  • Accordingly, restated figures for 2013 for comparison purposes
  • Outlook for 2014 and financial objectives for 2016 unchanged

Brussels, April 7, 2014 --- Solvay publishes today restated financial figures for 2013 due to the application of the new International Financial Reporting Standards (IFRS) 10 (Consolidated Financial Statements), 11 (Joint Arrangements) and 12 (Disclosures of Interests in Other Entities). The Group is applying these new standards effective since January 1, 2014.

Solvay's restated figures for 2013 provide a basis for comparison for its upcoming first quarter results for 2014, which will be published on May 6, and for subsequent periods.

Furthermore, the restated figures reflect the changes in the Group Segment information consisting in the split of Solvay's Global Business Unit (GBU) Essential Chemicals into two GBUs: Soda Ash & Derivatives and Peroxides also effective since January 1, 2014.

The application of IFRS 10 does not lead to a change in scope of fully consolidated entities for the Solvay Group.

Application of IFRS 11 has led to a change in consolidation scope of some joint arrangements that qualify as joint operations, and therefore will now be proportionally consolidated, which previously were accounted for by using the equity method. The change in consolidation scope impacts the following activities:

Soda Ash & Derivatives operations/interests in Devnya (Bulgaria), 75% held by Solvay and comprising the following legal entities:

  • Deven AD;
  • Solvay Sodi AD;
  • Solvay Sisecam Holding AG;

Hydrogen Peroxide Propylene Oxide (HPPO) operations/interests in Zandvliet (Belgium), Map Ta Put (Thailand) and the HPPO plant that is being constructed in the Kingdom of Saudi Arabia, all 50% held by the Solvay Group and comprising the following legal entities:

  • BASF Interox H2O2 Production NV;
  • MTP HPJV C.V.;
  • MTP HPJV Management B.V.;
  • MTP HPJV (Thailand) Ltd.;
  • Saudi Hydrogen Peroxide Co.;

Overall, the application of IFRS 11 does not impact reported 2013 Solvay Group Net Income but, there are impacts at the following levels:


ARIVA.DE Börsen-Geflüster

Werbung

Weiter aufwärts?

Kurzfristig positionieren in Solvay
ME5ATT
Ask: 1,08
Hebel: 5,54
mit moderatem Hebel
Zum Produkt
Smartbroker
Morgan Stanley
Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie hier: ME5ATT,. Beachten Sie auch die weiteren Hinweise zu dieser Werbung. Der Emittent ist berechtigt, Wertpapiere mit open end-Laufzeit zu kündigen.

Kurse

33,00 $
+1,41%
Solvay Chart

On the Full Year 2013 Income Statement (fully ascribed to the Essential Chemicals GBU):

  • net sales: + € 65 million
  • REBITDA: + € 41 million
  • underlying tax rate: 34% vs 36% before restatement

On the Full Year 2013 Cash Flow Statement

  • Capex: + € 57  million
  • Free Cash Flow: - € 37 million

On the Balance Sheet as of December 31, 2013

  • Net Debt: increase of € 40 million

Outlook for 2014 and financial objectives for 2016 unchanged
These accounting restatements had been taken into account in the formulation of Solvay's previous profit outlook statements for 2014 and 2016

Further information and 2013 restated figures can be found on our website under the following link:

http://www.solvay.com/en/investors/index.html

Solvay seeks to give, as much as possible, advance notice of future restatements. Apart from further changes in IFRS, the Group only anticipates significant future portfolio changes to impact the presentation of the results.

The first quarter 2014 earnings will be released on May 6, 2014.

       Follow us on twitter @SolvayGroup

As an international chemical group, Solvay assists industries in finding and implementing ever more responsible and value-creating solutions. Solvay generates 90% of its net sales in activities where it is among the world's top three players. It serves many markets, varying from energy and the environment to automotive and aerospace or electricity and electronics, with one goal: to raise the performance of its clients and improve society's quality of life. The group is headquartered in Brussels, employs about 29,400 people in 55 countries and generated 9.9 billion euros in net sales in 2013. Solvay SA SOLB.BE) is listed on NYSE Euronext in Brussels and Paris (Bloomberg: SOLB.BB - Reuters: SOLBt.BR).

Lamia Narcisse
Media Relations
+33 1 53 56 59 62
Caroline Jacobs
Media Relations
+32 2 264 1530
Maria Alcon
Investor Relations
+32 2 264 1984
Geoffroy Raskin
Investor Relations
+32 2 264 1540
Edward Mackay
Investor Relations
+32 2 264 3687



This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Solvay S.A. via Globenewswire

HUG#1774581
Werbung

Mehr Nachrichten zur Solvay Aktie kostenlos abonnieren

E-Mail-Adresse
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.


Andere Nutzer interessierten sich auch für folgende News